MétaCan
Menu
Back to cohort
Record W2327002222 · doi:10.1093/neuonc/nov061.91

MB-15 * ACTIVATED Wnt SIGNALING TARGETS Sox2+ TREATMENT-REFRACTORY Shh-DEPENDENT MEDULLOBLASTOMA STEM CELLS

2015· article· en· W2327002222 on OpenAlexaff
Branavan Manoranjan, Chitra Venugopal, Sujeivan Mahendram, Steven Moreira, Robin Hallett, Thusyanth Vijayakumar, David Bakhshinyan, Nicole McFarlane, John A. Hassell, Bradley W. Doble, Sheila K. Singh

Bibliographic record

VenueNeuro-Oncology · 2015
Typearticle
Languageen
FieldBiochemistry, Genetics and Molecular Biology
TopicMicroRNA in disease regulation
Canadian institutionsMcMaster University
Fundersnot available
KeywordsMedulloblastomaSOX2Wnt signaling pathwayCancer researchStem cellRefractory (planetary science)ChemistryCell biologyBiologySignal transductionBiochemistryTranscription factorAstrobiologyGene

Abstract

fetched live from OpenAlex

Medulloblastoma (MB) represents the most frequent malignant pediatric brain tumor. Since MBs characterized by activated sonic hedgehog (Shh) signaling continue to pose significant challenges due to treatment resistance, we aimed to prospectively identify, characterize, and target treatment-refractory Shh-dependent MB stem cells. Using gene expression and clinical outcome data from 325 primary human MBs, we identified Sox2high patients to exclusively represent treatment-refractory Shh MB. In order to prospectively characterize Sox2+ MB stem cells, we took advantage of the CRISPR-Cas9-nickase system to knock-in a P2A-mAG sequence into the Sox2 locus. By using our Sox2 reporter we show enchanced and reduced Sox2 expression in response to small molecule Shh agonists and inhibitors, respectively. Subsequent co-enrichment of Gli1/2 and H3K4me3 at the Sox2 promoter confirmed Sox2 as a downstream target in MB. In order to establish the clinical significance of this mechanism, we treated xenografts with a modified COG ACNS0332 radio/chemo-therapy protocol and prospectively tracked the in vivo evolution of Sox2+ cells. Molecular and functional analyses following treatment yielded an increase in Sox2 expression and self-renewal potential. Given the excellent clinical outcome in Wnt-driven MB patients, we aimed to convert treatment-resistant Sox2high MB into an ostensibly benign tumor using small molecule Wnt agonists. Wnt treatment resulted in a xenograft survival advantage and complete eradication of Sox2+ MB cells. Our work demonstrates mechanistic insight into the regulation of Sox2 by the Shh pathway and the clinical importance of this interaction by identifying Sox2 as a marker of treatment-resistant Shh MB stem cells. Our treatment model has enabled us to prospectively track the evolution of Sox2+ cells in vivo and thereby target these cells upon relapse. We have futher provided evidence for a novel therapeutic approach in converting aggressive MBs into a clinically-treatable tumor, which may improve the overall survival of children with treatment-refractory Shh-dependent MB.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.000
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Bench or experimental · Consensus signal: Bench or experimental
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.002
Threshold uncertainty score0.003

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0000.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0010.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.022
GPT teacher head0.272
Teacher spread0.250 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designBench or experimental
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2015
Admission routes1
Has abstractyes

Explore more

Same venueNeuro-OncologySame topicMicroRNA in disease regulationFrench-language works237,207